Graeme C Smith1, Thomas Trauer, Peter G Kerr, Steven J Chadban. 1. Consultation-Liaison Psychiatry Service and Monash University Department of Psychological Medicine, Monash Medical Centre, Southern Health, Clayton VIC 3168, Australia. graeme.smith@med.monash.edu.au
Abstract
BACKGROUND: Lack of prospective psychosocial outcome studies on living kidney donors impedes identification of risk factors for poor outcome. METHODS: Psychiatric assessment of living kidney donors was performed preoperatively and at 4 and 12 months postoperatively using a semistructured interview, the Short Form (SF)-36 Health Survey, and Patient Health Questionnaire psychiatric assessment. A total of 48 of 51 consecutive donors (94%) over a 5-year period were available for follow-up and completed all assessments. RESULTS: At preoperative assessment, only 1 of the 48 donors (2%) had a Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition Axis I psychiatric disorder, but 15 (31%) developed a disorder during the 12 months, a 29% incidence. Disorders were depressive (12%), anxiety (6%), and adjustment (13%). Seven donors (15%) demonstrated a disorder at 12 months (depressive 10%, anxiety 2%, adjustment 2%). There was a corresponding decline in psychosocial function as measured by the SF-36 Mental Component Summary score; it decreased at both 4 and 12 months (P<0.01, P<0.05); for 19% of donors, this was a larger decrease than would be expected for the cohort (>2 standard error of measurement units). Scores for SF-36 scales of General Health and Vitality decreased significantly (P<0.05), as did those of Bodily Pain, indicating greater impairment from pain. Psychiatric disorder at 12 months was associated with donor psychosocial function (Mental Component Summary) and psychiatric disorder at 4 months (P<0.01), physical function (SF-36 Physical Component Summary score) at 4 and 12 months (P<0.01), and recipient psychiatric disorder at 12 months (P<0.05). CONCLUSIONS: Donors should be alerted to possible psychosocial impairment, assessed for risk factors, and monitored for at least 12 months. Treatment should be available.
BACKGROUND: Lack of prospective psychosocial outcome studies on living kidney donors impedes identification of risk factors for poor outcome. METHODS:Psychiatric assessment of living kidney donors was performed preoperatively and at 4 and 12 months postoperatively using a semistructured interview, the Short Form (SF)-36 Health Survey, and Patient Health Questionnaire psychiatric assessment. A total of 48 of 51 consecutive donors (94%) over a 5-year period were available for follow-up and completed all assessments. RESULTS: At preoperative assessment, only 1 of the 48 donors (2%) had a Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition Axis I psychiatric disorder, but 15 (31%) developed a disorder during the 12 months, a 29% incidence. Disorders were depressive (12%), anxiety (6%), and adjustment (13%). Seven donors (15%) demonstrated a disorder at 12 months (depressive 10%, anxiety 2%, adjustment 2%). There was a corresponding decline in psychosocial function as measured by the SF-36 Mental Component Summary score; it decreased at both 4 and 12 months (P<0.01, P<0.05); for 19% of donors, this was a larger decrease than would be expected for the cohort (>2 standard error of measurement units). Scores for SF-36 scales of General Health and Vitality decreased significantly (P<0.05), as did those of Bodily Pain, indicating greater impairment from pain. Psychiatric disorder at 12 months was associated with donorpsychosocial function (Mental Component Summary) and psychiatric disorder at 4 months (P<0.01), physical function (SF-36 Physical Component Summary score) at 4 and 12 months (P<0.01), and recipient psychiatric disorder at 12 months (P<0.05). CONCLUSIONS: Donors should be alerted to possible psychosocial impairment, assessed for risk factors, and monitored for at least 12 months. Treatment should be available.
Authors: Camilla S Hanson; Jeremy R Chapman; John S Gill; John Kanellis; Germaine Wong; Jonathan C Craig; Armando Teixeira-Pinto; Steve J Chadban; Amit X Garg; Angelique F Ralph; Jule Pinter; Joshua R Lewis; Allison Tong Journal: Clin J Am Soc Nephrol Date: 2018-05-31 Impact factor: 8.237
Authors: Courtenay M Holscher; Kyle Jackson; Eric K H Chow; Alvin G Thomas; Christine E Haugen; Sandra R DiBrito; Carlin Purcell; Matthew Ronin; Amy D Waterman; Jacqueline Garonzik Wang; Allan B Massie; Sommer E Gentry; Dorry L Segev Journal: Am J Transplant Date: 2018-03-09 Impact factor: 8.086
Authors: S G Jowsey; C Jacobs; C R Gross; B A Hong; E E Messersmith; B W Gillespie; T J Beebe; C Kew; A Matas; R D Yusen; M Hill-Callahan; J Odim; S J Taler Journal: Am J Transplant Date: 2014-10-07 Impact factor: 8.086
Authors: M A Dew; A F DiMartini; A J DeVito Dabbs; A Zuckoff; H P Tan; M L McNulty; G E Switzer; K R Fox; J B Greenhouse; A Humar Journal: Am J Transplant Date: 2013-08-07 Impact factor: 8.086
Authors: Mary Amanda Dew; Allan Zuckoff; Andrea F DiMartini; Annette J DeVito Dabbs; Mary L McNulty; Kristen R Fox; Galen E Switzer; Abhinav Humar; Henkie P Tan Journal: Prog Transplant Date: 2012-09 Impact factor: 1.187
Authors: Barbara Suwelack; Viktoriya Wörmann; Klaus Berger; Joachim Gerß; Heiner Wolters; Frank Vitinius; Markus Burgmer Journal: BMC Nephrol Date: 2018-04-10 Impact factor: 2.388